Arcellx (ACLX) Other Accumulated Expenses (2021 - 2025)
Arcellx's (ACLX) quarterly Other Accumulated Expenses came in at $4.4 million in Q4 2025, down 48.89% year-on-year from $8.5 million in Q4 2024, and down 35.6% quarter-over-quarter from $6.8 million in Q3 2025.
Arcellx (ACLX) Other Accumulated Expenses (2021 - 2025) Analysis & Trends
Arcellx's Other Accumulated Expenses history runs 5 years deep, the most recent figure standing at $4.4 million for Q4 2025.
- On a quarterly basis, Other Accumulated Expenses fell 48.89% year-over-year to $4.4 million in Q4 2025; TTM through Dec 2025 was $4.4 million, a 48.89% decrease from a year earlier, with the FY2025 full-year figure at $4.4 million, down 48.89% from the prior year.
- Other Accumulated Expenses retreated to $4.4 million in Q4 2025 per ACLX's latest filing, from $6.8 million in the prior quarter.
- Across five years, Other Accumulated Expenses topped out at $26.9 million in Q2 2024 and bottomed at $149000.0 in Q4 2021.
- The 5-year median for Other Accumulated Expenses is $7.4 million (2025), against an average of $8.8 million.
- Across the five-year window, Other Accumulated Expenses soared 4720.12% in 2023 and plunged 72.91% in 2025, its largest moves.
- Year by year, Other Accumulated Expenses stood at $149000.0 in 2021, then surged by 2001.34% to $3.1 million in 2022, then jumped by 162.34% to $8.2 million in 2023, then increased by 3.86% to $8.5 million in 2024, then tumbled by 48.89% to $4.4 million in 2025.
- Per Business Quant, the three latest ACLX Other Accumulated Expenses figures stand at $4.4 million (Q4 2025), $6.8 million (Q3 2025), and $8.5 million (Q2 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arcellx | 6.48 Bn | 6.48 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 4.36 Mn |
| Sep 30, 2025 | 6.77 Mn |
| Jun 30, 2025 | 8.51 Mn |
| Mar 31, 2025 | 7.36 Mn |
| Dec 31, 2024 | 8.53 Mn |
| Sep 30, 2024 | 24.99 Mn |
| Jun 30, 2024 | 26.90 Mn |
| Mar 31, 2024 | 23.63 Mn |
| Dec 31, 2023 | 8.21 Mn |
| Sep 30, 2023 | 10.22 Mn |
| Jun 30, 2023 | 5.02 Mn |
| Mar 31, 2023 | 7.91 Mn |
| Dec 31, 2022 | 3.13 Mn |
| Sep 30, 2022 | 1.84 Mn |
| Jun 30, 2022 | 1.66 Mn |
| Mar 31, 2022 | 164,000.00 |
| Dec 31, 2021 | 149,000.00 |